Bioinformatic Analysis of Peripheral Blood miRNA of Breast Cancer Patients in Relation With Anthracycline Cardiotoxicity

BMC Cardiovascular Disorders - United Kingdom
doi 10.1186/s12872-020-01346-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Radionuclide Methods in the Detection and Forecast of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients

Siberian Journal of Oncology
Cancer ResearchOncology
2016English

Anthracycline Cardiotoxicity

2012English

Strategies to Prevent Anthracycline-Induced Cardiotoxicity in Cancer Survivors

Cardio-Oncology
2019English

Cardiotoxicity of Anthracycline Therapy: Current Perspectives

Archives of Medical Science
Medicine
2016English

Role of Nebivolol in Anthracycline-Induced Cardiotoxicity

International Journal of Research in Medical Sciences
2019English

Evaluation of miRNA-135a and miRNA-9 as Prognostic Markers in Breast Cancer Patients

Madridge Journal of Oncogenesis
2019English

Heart Rate Variability During and After Chemotherapy With Anthracycline in Patients With Breast Cancer

Kardiologia Polska
Cardiovascular MedicineCardiology
2018English

DNA Methylation of Immune Checkpoints in the Peripheral Blood of Breast and Colorectal Cancer Patients

OncoImmunology
OncologyAllergyImmunology
2018English

Analysis of the Treg Cell Population in the Peripheral Blood of Ovarian Cancer Patients in Relation to the Long-Term Outcomes

Ginekologia Polska
GynecologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy